Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2022 Filed Nov 17, 2022 23:09 UTC |
Winer Gary MDirector
|
PurchaseCommon Stock | 1,500 | $4.10 | $6,150.00 |
DisclosureSEC source: 0000899243-22-036222 · doc4.xml · nonDerivative · entry 2 Winer Gary M · CIK 0001822095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,052 Read SEC document |
| November 16, 2022 Filed Nov 17, 2022 23:09 UTC |
Winer Gary MDirector
|
PurchaseCommon Stock | 1,000 | $4.25 | $4,250.00 |
DisclosureSEC source: 0000899243-22-036222 · doc4.xml · nonDerivative · entry 1 Winer Gary M · CIK 0001822095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,552 Read SEC document |
| August 18, 2022 Filed Aug 22, 2022 20:57 UTC |
Winer Gary MDirector
|
PurchaseCommon Stock | 2,000 | $6.00 | $12,000.00 |
DisclosureSEC source: 0000899243-22-029447 · doc4.xml · nonDerivative · entry 3 Winer Gary M · CIK 0001822095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,552 Read SEC document |
| August 17, 2022 Filed Aug 22, 2022 20:57 UTC |
Winer Gary MDirector
|
PurchaseCommon Stock | 2,000 | $6.00 | $12,000.00 |
DisclosureSEC source: 0000899243-22-029447 · doc4.xml · nonDerivative · entry 2 Winer Gary M · CIK 0001822095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,552 Read SEC document |
| August 17, 2022 Filed Aug 22, 2022 20:57 UTC |
Winer Gary MDirector
|
PurchaseCommon Stock | 1,000 | $6.15 | $6,150.00 |
DisclosureSEC source: 0000899243-22-029447 · doc4.xml · nonDerivative · entry 1 Winer Gary M · CIK 0001822095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,552 Read SEC document |
| May 25, 2022 Filed May 27, 2022 19:54 UTC |
LINDSTROM RICHARD L MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,616 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020012 · doc4.xml · derivative · entry 2 LINDSTROM RICHARD L MD · CIK 0001242177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,616 Underlying: Common Stock · 15,616 shares Expires 2032-05-25 F2 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. Read SEC document |
| May 25, 2022 Filed May 27, 2022 19:54 UTC |
LINDSTROM RICHARD L MDDirector
|
GrantCommon Stock | 4,285 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020012 · doc4.xml · nonDerivative · entry 1 LINDSTROM RICHARD L MD · CIK 0001242177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,748 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. Read SEC document |
| May 25, 2022 Filed May 27, 2022 23:59 UTC |
WEISNER AIMEE SDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,616 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020017 · doc4.xml · derivative · entry 2 WEISNER AIMEE S · CIK 0001227308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,616 Underlying: Common Stock · 15,616 shares Expires 2032-05-25 F2 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. Read SEC document |
| May 25, 2022 Filed May 27, 2022 23:59 UTC |
WEISNER AIMEE SDirector
|
GrantCommon Stock | 4,285 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020017 · doc4.xml · nonDerivative · entry 1 WEISNER AIMEE S · CIK 0001227308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,285 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. Read SEC document |
| May 25, 2022 Filed May 27, 2022 21:27 UTC |
MCLAUGHLIN JOHN PETERDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,616 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020055 · doc4.xml · derivative · entry 2 MCLAUGHLIN JOHN PETER · CIK 0001277967 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,616 Underlying: Common Stock · 15,616 shares Expires 2032-05-25 F3 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. Read SEC document |
| May 25, 2022 Filed May 27, 2022 21:27 UTC |
MCLAUGHLIN JOHN PETERDirector
|
GrantCommon Stock | 4,285 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020055 · doc4.xml · nonDerivative · entry 1 MCLAUGHLIN JOHN PETER · CIK 0001277967 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,343 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer F2 · balance_after: Includes 40,058 shares of the Issuer's common stock received by the Reporting Person in connection with the October 1, 2020 spin-off (the "Spin-Off Date") of the Issuer from PDL BioPharma, Inc. ("PDL") on account of his ownership of shares of PDL common stock. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:24 UTC |
O'Farrell Elizabeth G.Director
|
GrantStock Option (Right to Buy) · Derivative | 15,616 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020053 · doc4.xml · derivative · entry 2 O'Farrell Elizabeth G. · CIK 0001744662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,616 Underlying: Common Stock · 15,616 shares Expires 2032-05-25 F3 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. Read SEC document |
| May 25, 2022 Filed May 28, 2022 01:24 UTC |
O'Farrell Elizabeth G.Director
|
GrantCommon Stock | 4,285 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020053 · doc4.xml · nonDerivative · entry 1 O'Farrell Elizabeth G. · CIK 0001744662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,285 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. F2 · balance_after: Includes 7,000 shares of the Issuer's common stock inadvertently omitted from the Reporting Person's original Form 3. Read SEC document |
| May 25, 2022 Filed May 28, 2022 00:01 UTC |
Winer Gary MDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,616 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020022 · doc4.xml · derivative · entry 2 Winer Gary M · CIK 0001822095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,616 Underlying: Common Stock · 15,616 shares Expires 2032-05-25 F2 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. Read SEC document |
| May 25, 2022 Filed May 28, 2022 00:01 UTC |
Winer Gary MDirector
|
GrantCommon Stock | 4,285 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020022 · doc4.xml · nonDerivative · entry 1 Winer Gary M · CIK 0001822095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,552 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. Read SEC document |
| May 25, 2022 Filed May 31, 2022 15:44 UTC |
LINK WILLIAM J PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,616 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020097 · doc4.xml · derivative · entry 2 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,616 Underlying: Common Stock · 15,616 shares Expires 2032-05-25 F2 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 25, 2022, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. The option was granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. Read SEC document |
| May 25, 2022 Filed May 31, 2022 15:44 UTC |
LINK WILLIAM J PHDDirector
|
GrantCommon Stock | 4,285 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020097 · doc4.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,979 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in full on May 25, 2023, subject to the Reporting Person's continued service to the Issuer through the vesting date. The RSUs were granted in accordance with the Issuer's non-employee director compensation program as a component of the Reporting Person's annual compensation for service to the Issuer. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 22:20 UTC |
Connaughton Alan B.Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 52,500 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0000899243-22-001922 · doc4.xml · derivative · entry 2 Connaughton Alan B. · CIK 0001822199 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2032-01-11 F2 · derivative.exercise_date: The option vests as to 25% of the award on January 11, 2023 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 22:20 UTC |
Connaughton Alan B.Chief Operating Officer
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001922 · doc4.xml · nonDerivative · entry 1 Connaughton Alan B. · CIK 0001822199 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,221 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in four (4) substantially equal annual installments on each anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 22:20 UTC |
CURTIS NICHOLAS TDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 105,000 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0000899243-22-001923 · doc4.xml · derivative · entry 2 CURTIS NICHOLAS T · CIK 0001230265 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2032-01-11 F2 · derivative.exercise_date: The option vests as to 25% of the award on January 11, 2023 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 22:20 UTC |
CURTIS NICHOLAS TDirector · Chief Executive Officer
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001923 · doc4.xml · nonDerivative · entry 1 CURTIS NICHOLAS T · CIK 0001230265 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 770,850 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in four (4) substantially equal annual installments on each anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 22:20 UTC |
STAAB THOMAS R IIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 52,500 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0000899243-22-001924 · doc4.xml · derivative · entry 2 STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 52,500 shares Expires 2032-01-11 F2 · derivative.exercise_date: The option vests as to 25% of the award on January 11, 2023 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 22:20 UTC |
STAAB THOMAS R IIChief Financial Officer
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-001924 · doc4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,409 F1 · shares: Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of LENSAR, Inc. common stock. The RSUs vest in four (4) substantially equal annual installments on each anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 22:20 UTC |
Wong KendraPrincipal Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 21,970 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0000899243-22-001921 · doc4.xml · derivative · entry 1 Wong Kendra · CIK 0001903906 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,970 Underlying: Common Stock · 21,970 shares Expires 2032-01-11 F1 · derivative.exercise_date: The option vests as to 25% of the award on January 11, 2023 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 16:15 UTC |
LINDSTROM RICHARD L MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,847 | $0.00 Strike: $7.49 | $0.00 |
DisclosureSEC source: 0000899243-21-020138 · doc4.xml · derivative · entry 1 LINDSTROM RICHARD L MD · CIK 0001242177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,847 Underlying: Common Stock · 20,847 shares Expires 2031-05-18 F1 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 18, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:15 UTC |
LINK WILLIAM J PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,847 | $0.00 Strike: $7.49 | $0.00 |
DisclosureSEC source: 0000899243-21-020140 · doc4.xml · derivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,847 Underlying: Common Stock · 20,847 shares Expires 2031-05-18 F1 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 18, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:15 UTC |
WEISNER AIMEE SDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,847 | $0.00 Strike: $7.49 | $0.00 |
DisclosureSEC source: 0000899243-21-020149 · doc4.xml · derivative · entry 1 WEISNER AIMEE S · CIK 0001227308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,847 Underlying: Common Stock · 20,847 shares Expires 2031-05-18 F1 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 18, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 16:15 UTC |
MCLAUGHLIN JOHN PETERDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,847 | $0.00 Strike: $7.49 | $0.00 |
DisclosureSEC source: 0000899243-21-020137 · doc4.xml · derivative · entry 1 MCLAUGHLIN JOHN PETER · CIK 0001277967 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,847 Underlying: Common Stock · 20,847 shares Expires 2031-05-18 F1 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 18, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:15 UTC |
O'Farrell Elizabeth G.Director
|
GrantStock Option (Right to Buy) · Derivative | 20,847 | $0.00 Strike: $7.49 | $0.00 |
DisclosureSEC source: 0000899243-21-020142 · doc4.xml · derivative · entry 1 O'Farrell Elizabeth G. · CIK 0001744662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,847 Underlying: Common Stock · 20,847 shares Expires 2031-05-18 F1 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 18, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| May 18, 2021 Filed May 20, 2021 20:15 UTC |
Winer Gary MDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,847 | $0.00 Strike: $7.49 | $0.00 |
DisclosureSEC source: 0000899243-21-020144 · doc4.xml · derivative · entry 1 Winer Gary M · CIK 0001822095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,847 Underlying: Common Stock · 20,847 shares Expires 2031-05-18 F1 · derivative.exercise_date: The option vests in twelve (12) substantially equal monthly installments commencing June 18, 2021, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 13:01 UTC |
Connaughton Alan B.Chief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 49,197 | $0.00 Strike: $6.91 | $0.00 |
DisclosureSEC source: 0000899243-21-015712 · doc4.xml · derivative · entry 1 Connaughton Alan B. · CIK 0001822199 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,197 Underlying: Common Stock · 49,197 shares Expires 2031-04-12 F1 · derivative.exercise_date: The option vests as to 25% of the award on April 12, 2022 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 13:02 UTC |
CURTIS NICHOLAS TDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 98,394 | $0.00 Strike: $6.91 | $0.00 |
DisclosureSEC source: 0000899243-21-015713 · doc4.xml · derivative · entry 1 CURTIS NICHOLAS T · CIK 0001230265 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,394 Underlying: Common Stock · 98,394 shares Expires 2031-04-12 F1 · derivative.exercise_date: The option vests as to 25% of the award on April 12, 2022 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 13:00 UTC |
STAAB THOMAS R IIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 49,197 | $0.00 Strike: $6.91 | $0.00 |
DisclosureSEC source: 0000899243-21-015711 · doc4.xml · derivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,197 Underlying: Common Stock · 49,197 shares Expires 2031-04-12 F1 · derivative.exercise_date: The option vests as to 25% of the award on April 12, 2022 and, as to the remaining amount of the award, in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:09 UTC |
WEISNER AIMEE SDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,445 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0000899243-21-011933 · doc4.xml · derivative · entry 1 WEISNER AIMEE S · CIK 0001227308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,445 Underlying: Common Stock · 13,445 shares Expires 2031-03-12 F1 · derivative.exercise_date: The option vests as to one-third of the award on February 1, 2022 and, as to the remaining amount of the award, in twenty-four (24) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 16:07 UTC |
MCLAUGHLIN JOHN PETERDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,445 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0000899243-21-011932 · doc4.xml · derivative · entry 1 MCLAUGHLIN JOHN PETER · CIK 0001277967 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,445 Underlying: Common Stock · 13,445 shares Expires 2031-03-12 F1 · derivative.exercise_date: The option vests as to one-third of the award on February 1, 2022 and, as to the remaining amount of the award, in twenty-four (24) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| March 12, 2021 Filed Mar 16, 2021 20:13 UTC |
O'Farrell Elizabeth G.Director
|
GrantStock Option (Right to Buy) · Derivative | 13,445 | $0.00 Strike: $8.62 | $0.00 |
DisclosureSEC source: 0000899243-21-011935 · doc4.xml · derivative · entry 1 O'Farrell Elizabeth G. · CIK 0001744662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,445 Underlying: Common Stock · 13,445 shares Expires 2031-03-12 F1 · derivative.exercise_date: The option vests as to one-third of the award on February 1, 2022 and, as to the remaining amount of the award, in twenty-four (24) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 21:10 UTC |
WEISNER AIMEE SDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,249 | $0.00 Strike: $7.08 | $0.00 |
DisclosureSEC source: 0000899243-21-004177 · doc4.xml · derivative · entry 1 WEISNER AIMEE S · CIK 0001227308 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,249 Underlying: Common Stock · 28,249 shares Expires 2031-02-01 F1 · derivative.exercise_date: The option vests as to one-third of the award on February 1, 2022 and, as to the remaining amount of the award, in twenty-four (24) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 16:10 UTC |
MCLAUGHLIN JOHN PETERDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,249 | $0.00 Strike: $7.08 | $0.00 |
DisclosureSEC source: 0000899243-21-004175 · doc4.xml · derivative · entry 1 MCLAUGHLIN JOHN PETER · CIK 0001277967 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,249 Underlying: Common Stock · 28,249 shares Expires 2031-02-01 F1 · derivative.exercise_date: The option vests as to one-third of the award on February 1, 2022 and, as to the remaining amount of the award, in twenty-four (24) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 21:10 UTC |
O'Farrell Elizabeth G.Director
|
GrantStock Option (Right to Buy) · Derivative | 28,249 | $0.00 Strike: $7.08 | $0.00 |
DisclosureSEC source: 0000899243-21-004176 · doc4.xml · derivative · entry 1 O'Farrell Elizabeth G. · CIK 0001744662 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,249 Underlying: Common Stock · 28,249 shares Expires 2031-02-01 F1 · derivative.exercise_date: The option vests as to one-third of the award on February 1, 2022 and, as to the remaining amount of the award, in twenty-four (24) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date. Read SEC document |
| December 07, 2020 Filed Dec 11, 2020 01:53 UTC |
Connaughton Alan B.Chief Operating Officer
|
GrantCommon Stock | 39,195 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-033400 · doc4.xml · nonDerivative · entry 1 Connaughton Alan B. · CIK 0001822199 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,221 F1 · shares: Represents restricted stock awarded to the Reporting Person on December 7, 2020 in connection with an amendment on the same date to the restricted stock awarded to him on July 22, 2020 to amend and extend the vesting schedule applicable to such award (the "Original Award"). In order to comply with tax laws and to recognize the Reporting Person's agreement to an extension of the overall vesting schedule of the Original Award, the Reporting Person was issued the restricted stock award, which represents 20% of the total number of shares subject to the Original Award. The restricted stock award will vest on the same amended vesting schedule applicable to the Original Award, which amended vesting schedule provides for vesting in quarterly installments over the approximately three-year period following the amendment date. Read SEC document |
| December 07, 2020 Filed Dec 10, 2020 20:48 UTC |
LINDSTROM RICHARD L MDDirector
|
GrantCommon Stock | 32,127 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-033394 · doc4.xml · nonDerivative · entry 1 LINDSTROM RICHARD L MD · CIK 0001242177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,463 F1 · shares: Represents restricted stock awarded to the Reporting Person on December 7, 2020 in connection with an amendment on the same date to the restricted stock awarded to him on July 22, 2020 to amend and extend the vesting schedule applicable to such award (the "Original Award"). In order to comply with tax laws and to recognize the Reporting Person's agreement to an extension of the overall vesting schedule of the Original Award, the Reporting Person was issued the restricted stock award, which represents 20% of the total number of shares subject to the Original Award. The restricted stock award will vest on the same amended vesting schedule applicable to the Original Award, which amended vesting schedule provides for vesting in quarterly installments over the approximately three-year period following the amendment date. Read SEC document |
| December 07, 2020 Filed Dec 11, 2020 01:53 UTC |
LINK WILLIAM J PHDDirector
|
GrantCommon Stock | 80,157 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-033401 · doc4.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507,694 F1 · shares: Represents restricted stock awarded to the Reporting Person on December 7, 2020 in connection with an amendment on the same date to the restricted stock awarded to him on July 22, 2020 to amend and extend the vesting schedule applicable to such award (the "Original Award"). In order to comply with tax laws and to recognize the Reporting Person's agreement to an extension of the overall vesting schedule of the Original Award, the Reporting Person was issued the restricted stock award, which represents 20% of the total number of shares subject to the Original Award. The restricted stock award will vest on the same amended vesting schedule applicable to the Original Award, which amended vesting schedule provides for vesting in quarterly installments over the approximately three-year period following the amendment date. Read SEC document |
| December 07, 2020 Filed Dec 11, 2020 01:50 UTC |
CURTIS NICHOLAS TDirector · Chief Executive Officer
|
GrantCommon Stock | 116,622 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-033395 · doc4.xml · nonDerivative · entry 1 CURTIS NICHOLAS T · CIK 0001230265 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 731,585 F1 · shares: Represents restricted stock awarded to the Reporting Person on December 7, 2020 in connection with an amendment on the same date to the restricted stock awarded to him on July 22, 2020 to amend and extend the vesting schedule applicable to such award (the "Original Award"). In order to comply with tax laws and to recognize the Reporting Person's agreement to an extension of the overall vesting schedule of the Original Award, the Reporting Person was issued the restricted stock award, which represents 20% of the total number of shares subject to the Original Award. The restricted stock award will vest on the same amended vesting schedule applicable to the Original Award, which amended vesting schedule provides for vesting in quarterly installments over the approximately three-year period following the amendment date. Read SEC document |
| December 07, 2020 Filed Dec 11, 2020 01:50 UTC |
STAAB THOMAS R IIChief Financial Officer
|
GrantCommon Stock | 19,276 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-033396 · doc4.xml · nonDerivative · entry 1 STAAB THOMAS R II · CIK 0001230708 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,657 F1 · shares: Represents restricted stock awarded to the Reporting Person on December 7, 2020 in connection with an amendment on the same date to the restricted stock awarded to him on July 22, 2020 to amend and extend the vesting schedule applicable to such award (the "Original Award"). In order to comply with tax laws and to recognize the Reporting Person's agreement to an extension of the overall vesting schedule of the Original Award, the Reporting Person was issued the restricted stock award, which represents 20% of the total number of shares subject to the Original Award. The restricted stock award will vest on the same amended vesting schedule applicable to the Original Award, which amended vesting schedule provides for vesting in quarterly installments over the approximately three-year period following the amendment date. Read SEC document |
| December 07, 2020 Filed Dec 11, 2020 01:54 UTC |
Winer Gary MDirector
|
GrantCommon Stock | 4,026 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-033402 · doc4.xml · nonDerivative · entry 1 Winer Gary M · CIK 0001822095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,267 Read SEC document |
| October 06, 2020 Filed Oct 7, 2020 23:00 UTC |
Winer Gary MDirector
|
GrantCommon Stock | 51 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-027748 · doc4.xml · nonDerivative · entry 1 Winer Gary M · CIK 0001822095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,241 F1 · kind: Represents shares acquired from the Issuer as a result of a provision contained in the Reporting Person's restricted stock award agreement intended to maintain certain target ownership percentages of the Issuer's common stock in connection with the spin-off transaction. F1 · shares: Represents shares acquired from the Issuer as a result of a provision contained in the Reporting Person's restricted stock award agreement intended to maintain certain target ownership percentages of the Issuer's common stock in connection with the spin-off transaction. F2 · balance_after: Includes 20,130 shares of restricted stock. Read SEC document |
| October 01, 2020 Filed Oct 1, 2020 21:52 UTC |
PDL BIOPHARMA, INC.10% owner
|
OtherCommon Stock | 8,667,397 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-026691 · doc4.xml · nonDerivative · entry 2 PDL BIOPHARMA, INC. · CIK 0000882104 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: In connection with the separation of the Issuer from the Reporting Person on October 1, 2020, the Reporting Person distributed all of the shares of common stock of the Issuer in the form of a dividend to its stockholders. F1 · shares: In connection with the separation of the Issuer from the Reporting Person on October 1, 2020, the Reporting Person distributed all of the shares of common stock of the Issuer in the form of a dividend to its stockholders. Read SEC document |
| September 29, 2020 Filed Oct 1, 2020 21:52 UTC |
PDL BIOPHARMA, INC.10% owner
|
PurchaseCommon Stock | 8,703 | $11.16 | $97,125.48 |
DisclosureSEC source: 0000899243-20-026691 · doc4.xml · nonDerivative · entry 1 PDL BIOPHARMA, INC. · CIK 0000882104 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,667,397 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.